Oral potentially malignant disorders: A consensus report from an international seminar on nomenclature and classification, convened by the WHO Collaborating Centre for Oral Cancer
Top Cited Papers
- 31 October 2020
- journal article
- review article
- Published by Wiley in Oral Diseases
- Vol. 27 (8), 1862-1880
- https://doi.org/10.1111/odi.13704
Abstract
Oral potentially malignant disorders (OPMDs) are associated with an increased risk of occurrence of cancers of the lip or oral cavity. This paper presents an updated report on the nomenclature and the classification of OPMDs, based predominantly on their clinical features, following discussions by an expert group at a workshop held by the World Health Organisation (WHO) Collaborating Centre for Oral Cancer in the UK. The first workshop held in London in 2005 considered a wide spectrum of disorders under the term ‘potentially malignant disorders of the oral mucosa’ (PMD) (now referred to as oral potentially malignant disorders: OPMD) including leukoplakia, erythroplakia, proliferative verrucous leukoplakia, oral lichen planus, oral submucous fibrosis, palatal lesions in reverse smokers, lupus erythematosus, epidermolysis bullosa and dyskeratosis congenita. Any new evidence published in the intervening period was considered to make essential changes to the 2007 classification. In the current update, most entities were retained with minor changes to their definition. There is sufficient evidence for an increased risk of oral cancer among patients diagnosed with “oral lichenoid lesions” and among those diagnosed with oral manifestations of chronic graft‐versus‐host disease. These have now been added to the list of OPMDs. There is, to date, insufficient evidence concerning the malignant potential of chronic hyperplastic candidosis and of oral exophytic verrucous hyperplasia to consider these conditions as OPMDs. Furthermore, due to lack of clear evidence of an OPMD in epidermolysis bullosa this was moved to the category with limited evidence. We recommend the establishment of a global research consortium to further study the natural history of OPMDs based on the classification and nomenclature proposed here. This will require multi‐centre longitudinal studies with uniform diagnostic criteria to improve the identification and cancer risk stratification of patients with OPMDs, link them to evidence‐based interventions, with a goal to facilitate the prevention and management of lip and oral cavity cancer.Keywords
This publication has 136 references indexed in Scilit:
- The natural history of actinic keratosis: a systematic reviewBritish Journal of Dermatology, 2013
- Oral Lichenoid Contact Lesions to Mercury and Dental Amalgam—A ReviewJournal of Biomedicine and Biotechnology, 2012
- Proliferative multifocal leukoplakia better name that proliferative verrucous leukoplakiaWorld Journal of Surgical Oncology, 2011
- Oral epithelial dysplasia and squamous cell carcinoma following allogeneic hematopoietic stem cell transplantation: clinical presentation and treatment outcomesBone Marrow Transplantation, 2011
- Actinic cheilitis in dental practiceAustralian Dental Journal, 2010
- Oral Manifestations in the Epidermolysis Bullosa SpectrumDermatologic Clinics, 2010
- Dyskeratosis congenita: a case reportOral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, 2009
- A hypomorphic mouse model of dystrophic epidermolysis bullosa reveals mechanisms of disease and response to fibroblast therapyJCI Insight, 2008
- Current controversies in oral lichen planus: Report of an international consensus meeting. Part 1. Viral infections and etiopathogenesisOral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, 2005
- A review of the recent literature regarding malignant transformation of oral lichen planusOral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, 1999